Rhythm Pharmaceuticals, Inc. RYTM Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s financing cash flow?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported financing cash flow of -$5.4M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s financing cash flow changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s financing cash flow decreased by 116.6% year-over-year, from $32.5M to -$5.4M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s financing cash flow?
- Over 3 years (2021 to 2024), Rhythm Pharmaceuticals, Inc.'s financing cash flow has grown at a 4.7% compound annual growth rate (CAGR), from $166.48M to $191.24M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.